Northwest Biotherapeutics reported $494K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agenus USD 33.7M 500K Mar/2026
AstraZeneca USD 16.21B 830M Sep/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Celldex Therapeutics USD 400K 378K Sep/2026
Eisai JPY 235.63B 1.3B Sep/2026
Merck USD 18.1B 1.5B Sep/2026
Northwest Biotherapeutics USD 494K 294K Mar/2026
Pfizer USD 16.6B 1.57B Sep/2026
Plus Therapeutics USD 1.03M 339K Mar/2026
Roche Holding CHF 30.36B 14.71B Jun/2026